QA: Seelos Therapeutics INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2023_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 22,674,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 72,000
4 LiabilitiesCurrent 25,158,000
5 LiabilitiesNoncurrent 15,000
6 remainder_Liabilities 8,184,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,877,104
9 ResearchAndDevelopmentExpense 57,190,019
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -3,051,105
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,746,000
1 Liabilities 33,357,000
2 Expenses 69,067,123
3 Revenues 0
4 StockholdersEquity -10,611,000
5 NetIncome -72,118,228
6 ComprehensiveNetIncome -72,118,228
7 BaseVar 64,110,614
8 EconomicCapitalRatiobeforeLimitedLiability -3.40
9 EconomicCapitalRatio 0.561

Edgar->Model Mapping

Feature Distribution

Change over Time